Atezolizumab plus bevacizumab versus lenvatinib as first-line systemic therapy for treatment of hepatocellular carcinoma in a real-world population: Outcomes from the HCC CHORD database. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Freeman, Mark
  • Krishnan, Tharani
  • Lee, Cha Len
  • Dibajnia, Pooya
  • Ramjeesingh, Ravi
  • Vasconcelos, Joao Paulo Solar
  • Lyubetska, Hanna
  • Ding, Philip Q
  • Lim, Howard J
  • Knox, Jennifer J
  • Meyers, Brandon
  • Gordon, Vallerie Lynn
  • Cheung, Winson Y
  • Tam, Vincent C

publication date

  • June 1, 2024